137 related articles for article (PubMed ID: 12757828)
21. Comparison of the stimulus properties of a pre- vs. a putative postsynaptic dose of quinpirole.
Cory-Slechta DA; Zuch CL; Fox RA
Pharmacol Biochem Behav; 1996 Nov; 55(3):423-32. PubMed ID: 8951984
[TBL] [Abstract][Full Text] [Related]
22. Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats.
Drake JD; Kibuuka LN; Dimitrov KD; Pollack AE
Pharmacol Biochem Behav; 2013 Apr; 105():26-33. PubMed ID: 23369985
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes.
García-Sanz A; Badia A; Clos MV
Synapse; 2001 Apr; 40(1):65-73. PubMed ID: 11170223
[TBL] [Abstract][Full Text] [Related]
24. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
[TBL] [Abstract][Full Text] [Related]
25. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference.
Rodríguez De Fonseca F; Rubio P; Martín-Calderón JL; Caine SB; Koob GF; Navarro M
Eur J Pharmacol; 1995 Feb; 274(1-3):47-55. PubMed ID: 7768280
[TBL] [Abstract][Full Text] [Related]
26. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
[TBL] [Abstract][Full Text] [Related]
27. Dopamine receptor agonist- and antagonist-induced behaviors in primates previously treated with dopamine receptor antagonists: the pathogenetic mechanisms of acute oral dyskinesia.
Lublin H
Clin Neuropharmacol; 1995 Dec; 18(6):533-51. PubMed ID: 8681313
[TBL] [Abstract][Full Text] [Related]
28. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
Jeziorski M; White FJ
Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
[TBL] [Abstract][Full Text] [Related]
29. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
Koshikawa N; Kitamura M; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
[TBL] [Abstract][Full Text] [Related]
30. Role of 5-HT1A receptors in the ability of mixed 5-HT1A receptor agonist/dopamine D2 receptor antagonists to inhibit methylphenidate-induced behaviors in rats.
Kleven M; Prinssen EP; Koek W
Eur J Pharmacol; 1996 Oct; 313(1-2):25-34. PubMed ID: 8905325
[TBL] [Abstract][Full Text] [Related]
31. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
Meller E; Bordi F; Bohmaker K
Life Sci; 1988; 42(25):2561-7. PubMed ID: 3260320
[TBL] [Abstract][Full Text] [Related]
32. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
33. Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat.
Bachtell RK; Whisler K; Karanian D; Self DW
Psychopharmacology (Berl); 2005 Nov; 183(1):41-53. PubMed ID: 16163523
[TBL] [Abstract][Full Text] [Related]
34. Time-dependent actions of D2 family agonist quinpirole on spontaneous behavior in the rat: dissociation between sniffing and locomotion.
Horvitz JC; Williams G; Joy R
Psychopharmacology (Berl); 2001 Apr; 154(4):350-5. PubMed ID: 11349387
[TBL] [Abstract][Full Text] [Related]
35. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
Johnson EF; Szechtman H
Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
[TBL] [Abstract][Full Text] [Related]
36. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
37. Repeated 7-OH-DPAT treatments: behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine.
Mattingly BA; Fields SE; Langfels MS; Rowlett JK; Robinet PM; Bardo MT
Psychopharmacology (Berl); 1996 May; 125(1):33-42. PubMed ID: 8724446
[TBL] [Abstract][Full Text] [Related]
38. Behavioural effects of selective dopamine D-1 and D-2 agonists and antagonists in guinea-pigs.
Brent PJ
Psychopharmacology (Berl); 1991; 104(2):201-7. PubMed ID: 1831560
[TBL] [Abstract][Full Text] [Related]
39. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
[TBL] [Abstract][Full Text] [Related]
40. Modulation by sudden darkness of apomorphine-induced behavioral responses.
Nasello AG; Sassatani AS; Ferreira FS; Felicio LF; Tieppo CA
Physiol Behav; 2003 Apr; 78(4-5):521-8. PubMed ID: 12782204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
